Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Coca-Cola’s AI-powered José Mourinho campaign could signal a shift in celebrity partnerships
Instead of featuring José Mourinho, the incoming manager of the Real Madrid soccer team, the series will be hosted by Mourinho’s AI clone.
Nest New York brings its fragrance-layering strategy to the U.K.
The fragrance brand is expanding its U.K. presence through e-tailer Cult Beauty, department stores Harrods and Selfridges, and specialty retailer John Bell & Croyden.
Future of Marketing Briefing: How agencies are betting on entertainment to survive
Some agencies are done making ads. Now they want to make hits.